Partnering in the Global Generics Industry 2009

A guide to companies

Publication Date	October 2009
Publisher	Espicom
Product Type	Report
Pages	526
ISBN Number	not applicable
Product Code	ESP00549

Buy this product or for assistance call +44 20 7060 7474

PDF £595.00$990 | €666

PRINT £595.00$990 | €666

FAX Order above formats by FAX

Summary

Partnering is increasingly the choice for securing market share and business growth...

Teva's recent acquisition of Barr Pharmaceuticals may be the latest headline grabbing deal, but industry and commerce alike must have a complete understanding of the medium-sized generic drug manufacturers. The operating environment is changing rapidly as the industry matures and growth focuses on new market opportunities.

Consolidation continues to affect the market, with fewer big players dominating. Acquisition is still a favoured route to fast market access but strategic partnering is on the rise. In such a market you need to know...

But...
Who are the medium-sized companies of note?
How well do they perform?
What drugs do they produce?
Where are they located?

This report will tell you!

Identify merger, acquisition and partner candidates in the rapidly changing global generics market

Consolidation and collaboration runs throughout the generic industry. Here's just a taste of the acquisitions, controlling investments and deals in 2008/09...

Ascent to acquire Green Cross Pharma of Singapore
Aurobindo Pharma and Pfizer to commercialise off-patent products
Biocon and Mylan enter generic biologics development
Sanitas acquires Homeofarm
Hovione acquires Pfizer plant in Ireland
Adcock Ingram tried and failed to acquire Cipla Medpro
Hi-Tech Pharmacal acquires ECR Pharmaceuticals
URL Pharma acquires PharmPro manufacturing facility and equipment

Strategic partnering

In addition to outright purchase, strategic partnering or the acquisition of specific drug assets is on the rise as companies seek to bring lower costs and focus to their portfolios. With business cycles growing shorter and shorter, market entry is quicker and more reliable through acquisition and partnering.

The fundamental market drivers are sound

In addition to ongoing expansion, there are other drivers which are causing generic companies to consider the future:

Over the next 5 years over 40 blockbuster pharmaceutical products such as Lipitor, Cozaar, Effexor, Plavix, and Cymbalta will be losing patent protection.

The number of biologics coming into the remit of generic companies is increasing, raising interest in companies with biosimilars production capability.

The branded industry's response
The branded industry continues to vigorously protect its IP and maximise the lifetime value of its products. While legal initiatives will remain a key weapon there will also be commercial responses such as issuing early branded generics, collaborative working with a limited number of generic producers, new formulations or combination products.

Identify new business opportunities and assess risk
For everyone needing to evaluate the generic industry's competitive landscape, this thoroughly-researched and expanded 2nd edition of Partnering in the Global Generics Industry 2009: A guide to companies (published October 2009) is essential reading. In over 460 pages this new, completely revised edition references 170 generic companies operating in 40 markets around the world.

Content

Introduction
Argentina
- Osmotica Pharmaceutical
- Background
- Products
- Contact Details
Australia
- Ascent Pharmahealth
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Australian Pharmaceutical Industries
- Background
- Financials
- Major Developments
- Contact Details
- Hamilton Laboratories
- Background
- Products
- Contact Details
- Sigma Pharmaceuticals
- Background
- Products
- Financials
- Major Developments
- Contact Details
Austria
- Ebewe Pharma
- Background
- Products
- Financials
- Major Developments
- Contact Details
Bangladesh
- Beximco Pharmaceuticals
- Background
- Products
- Financials
- Major Developments
- Contact Details
Brazil
- Ache
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Americano
- Background
- Products
- Financials
- Contact Details
- Biolab
- Background
- Contact Details
- Cimed
- Background
- Products
- Financials
- Contact Details
- Cristalia
- Background
- Products
- Contact Details
- EMS-Sigma
- Background
- Products
- Financials
- Contact Details
- Eurofarma
- Background
- Contact Details
LAFEPE
- Background
- Products
- Contact Details
- Libbs Farmaceutica
- Background
- Financials
- Major Developments
- Contact Details
- Medley
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Prati-Donaduzzi
- Background
- Products
- Financials
- Contact Details
Bulgaria
- Sopharma
- Background
- Products
- Financials
- Contact Details
- Unipharm
- Background
- Contact Details
Canada
- Labopharm
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Orbus Pharma
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Pharmascience
- Background
- Products
- Major Developments
- Contact Details
Chile
- Andromaco
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Bestpharma
- Background
- Products
- Contact Details
- Biosano
- Background
- Products
- Financials
- Contact Details
- Maver
- Background
- Contact Details
- Mintlab
- Background
- Contact Details
China
- China Pharma Holdings
- Background
- Products
- Financials
- Contact Details
- Simcere Pharmaceutical Group
- Background
- Products
- Financials
- Major Developments
- Contact Details
Colombia
- Ecar
- Background
- Contact details
- Genfar
- Background
- Contact Details
- La Sante
- Background
- Contact Details
- Lafrancol
- Background
- Contact Details
Croatia
- Belupo
- Background
- Products
- Contact Details
Denmark
- Alternova
- Background
- Products
- Contact Details
- Orifarm
- Background
- Products
- Contact Details
Egypt
- EIPICo
- Background
- Contact Details
France
- Biogaran
- Background
- Contact Details
India
- Alembic
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Alkem Laboratories
- Background
- Products
- Major Developments
- Contact Details
- Aurobindo Pharma
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Biocon
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Emcure Pharmaceuticals
- Background
- Major Developments
- Contact Details
- Gland Pharma
- Background
- Products
- Contact Details
- Glenmark Pharmaceuticals
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Hetero Drugs
- Background
- Products
- Contact Details
- Indoco Remedies
- Background
- Products
- Financials
- Major Developments
- Contact Details
- JB Chemicals & Pharmaceuticals
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Jubilant Organosys
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Lupin Laboratories
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Natco Pharma
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Orchid Chemicals & Pharmaceuticals
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Strides Arcolab
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Sun Pharmaceutical Industries
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Torrent Pharmaceuticals
- Background
- Products
- Financials
- Major Developments
- Contact Details
- USV
- Background
- Products
- Contact Details
Indonesia
- Kimia
- Background
- Contact Details
Ireland
- Consilient Health
- Background
- Products
- Contact Details
- Reliance GeneMedix
- Background
- Products
- Financials
- Major Developments
- Contact Details
Israel
- Dexcel
- Background
- Products
- Major Developments
- Contact Details
- Taro Pharmaceutical Industries
- Background
- Products
- Financials
- Major Developments
- Contact Details
Italy
- Eurand
- Background
- Products
- Contact Details
Japan
- Nichi-iko Pharmaceutical
- Background
- Financials
- Major Developments
- Contact Details
- Towa Pharmaceutical
- Background
- Products
- Financials
- Major Developments
- Contact Details
Jordan
- Hikma
- Background
- Products
- Financials
- Major Developments
- Contact Details
Kenya
- Regal Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
Latvia
- Grindeks
- Background
- Products
- Financials
- Major Developments
- Contact Details
Lithuania
- Sanitas
- Background
- Products
- Financials
- Major Developments
- Contact Details
Malaysia
- CCM Pharmaceuticals
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Inno Biologics
- Background
- Products
- Contact Details
Mexico
- Laboratorios Kendrick
- Background
- Contact Details
- Laboratorios Silanes
- Background
- Contact Details
Pakistan
- CCL
- Background
- Contact Details
- Dr Raza Pharma
- Background
- Contact Details
- Epla Labs
- Background
- Products
- Contact Details
- Highnoon Laboratories
- Background
- Products
- Financials
- Contact Details
Peru
- Farmindustria
- Background
- Contact Details
- Induquimica
- Background
- Products
- Contact Details
- Infarmasa
- Background
- Financials
- Contact Details
Portugal
- Hovione FarmaCiencia
- Background
- Products
- Financials
- Major Developments
- Contact Details
Romania
- Antibiotice
- Background
- Products
- Financials
- Contact Details
- Europharm
- Background
- Contact Details
Russia
- Akrikhin
- Background
- Products
- Contact Details
- Bryntsalov A
- Background
- Contact Details
- Erka Farm
- Background
- Farmacon
- Background
- Contact Details
- Pharmstandard
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Veropharm
- Background
- Financials
- Contact Details
Saudi Arabia
- Tabuk Pharmaceutical Manufacturing
- Background
- Contact Details
Slovakia
- Biotika
- Background
- Financials
- Contact Details
South Africa
- Adcock Ingram
- Background
- Products
- Major Developments
- Contact Details
- Cipla Medpro
- Background
- Products
- Financials
- Major Developments
- Contact Details
Spain
- Combino Pharm
- Background
- Products
- Major Developments
- Contact Details
- Invent Farma Group
- Background
- Products
- Major Developments
- Contact Details
- Laboratorios Cinfa
- Background
- Products
- Major Developments
- Contact Details
Switzerland
- Acino Pharma
- Background
- Financials
- Contact Details
- Azad
- Background
- Products
- Major Developments
- Contact Details
- Helvepharm
- Background
- Contact Details
- Mepha Pharma
- Background
- Financials
- Contact Details
- Spirig
- Background
- Products
- Financials
- Contact Details
- Streuli
- Background
- Financials
- Contact Details
Turkey
- Abdi Ibrahim
- Background
- Products
- Major Developments
- Contact Details
- Bilim Pharmaceuticals
- Background
- Products
- Contact Details
- EastPharma
- Background
- Products
- Financials
- Contact Details
- Mustafa Nevzat Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
UK
- Goldshield Group
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Kent Pharmaceuticals
- Background
- Major Developments
- Contact Details
- ProStrakan
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Rosemont Pharmaceutical
- Background
- Products
- Major Developments
- Contact Details
USA
- APP Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
- Akorn
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Amneal Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
- Amphastar Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
- Anchen Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
- Banner Pharmacaps
- Background
- Products
- Major Developments
- Contact Details
- Bedford Laboratories
- Background
- Products
- Major Developments
- Contact Details
- Bio-Nucleonics
- Background
- Products
- Contact Details
- Boca Pharmacal
- Background
- Products
- Contact Details
- Caraco Pharmaceutical Laboratories
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Carolina Medical Products Company
- Background
- Products
- Contact Details
- Cedar Pharmaceuticals
- Background
- Products
- Contact Details
- Cephazone Pharma
- Background
- Products
- Contact Details
- CorePharma
- Background
- Products
- Major Developments
- Contact Details
- Cypress Pharmaceutical
- Background
- Products
- Major Developments
- Contact Details
- Ferndale Laboratories
- Background
- Products
- Major Developments
- Contact Details
- Fleming Pharmaceuticals
- Background
- Products
- Contact Details
- Fougera
- Background
- Products
- Major Developments
- Contact Details
- G&W Laboratories
- Background
- Products
- Contact Details
- GeneraMedix
- Background
- Products
- Major Developments
- Contact Details
- Glades Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
- GC Hanford Manufacturing
- Background
- Products
- Contact Details
- Harmony Labs
- Background
- Products
- Contact Details
- Heritage Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
- Hi-Tech Pharmacal
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Impax Laboratories
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Indicus Pharmaceuticals
- Background
- Products
- Contact Details
- InvaGen Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
- Kremers-Urban (KUDCo)
- Background
- Products
- Major Developments
- Contact Details
- KV Pharmaceutical
- Background
- Products
- Financials
- Major Developments
- Contact Details
- KVK-Tech
- Background
- Products
- Contact Details
- Luitpold Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
- Lyne Laboratories
- Background
- Products
- Contact Details
- Mallinckrodt
- Background
- Products
- Major Developments
- Contact Details
- Mikart
- Background
- Products
- Contact Details
- Neil Laboratories
- Background
- Products
- Contact Details
- Nephron Pharmaceuticals
- Background
- Products
- Contact Details
- Paddock Laboratories
- Background
- Products
- Major Developments
- Contact Details
- Parenta Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
- Pharmaceutical Associates
- Background
- Products
- Contact Details
- PharmaForce
- Background
- Products
- Contact Details
- Prasco
- Background
- Products
- Major Developments
- Contact Details
- Prometheus Laboratories
- Background
- Products
- Contact Details
- Roxane Laboratories
- Background
- Products
- Major Developments
- Contact Details
- RxElite Holdings
- Background
- Products
- Major Developments
- Contact Details
- Silarx Pharmaceuticals
- Background
- Products
- Contact Details
- Spear Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
- Stiefel
- Background
- Products
- Major Developments
- Contact Details
- SuperGen
- Background
- Products
- Financials
- Major Developments
- Contact Details
- Three Rivers Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
- URL Pharma
- Background
- Products
- Major Developments
- Contact Details
- Upsher-Smith Laboratories
- Background
- Products
- Major Developments
- Contact Details
- Vista Pharmaceuticals
- Background
- Products
- Contact Details
- VistaPharm
- Background
- Products
- Contact Details
- X-GEN Pharmaceuticals
- Background
- Products
- Major Developments
- Contact Details
- Venezuela
- Calox Internacional
- Background
- Contact Details
- Cofasa
- Background
- Contact Details
- Kimiceg
- Background
- Contact Details
- Leti
- Background
- Contact Details
- Meyer
- Background
- Contact Details
Index of Tables
- Companies in the report by country of origin
- Osmotica Pharmaceutical ANDA Approvals, 2002-09
- Ascent Pharmahealth: Reported Half-Year Results, 2007 - 2008 (A$000s)
- Australian Pharmaceutical Industries: Consoliated Results, FY2006 - FY2008 (A$000s)
- Sigma Pharmaceuticals: Financial Results, 2005 - 2009 (A$ millions)
- Ebewe Pharma ANDA Approvals, 2002-09
- Beximco Pharmaceuticals: 2002 - 2008 Results (BDT millions)
- Cimed: Sales, 2004 - 2007
- Cristalia.s Business Units, 2006
- Cristalia.s International Representatives, 2006
- EMS: Generics Registrations & Marketing Authorisations by Division, 2006
- EMS: Sales by Division, 2006
- LAFEPE: Product Lines, 2007
- Libbs Farmaceutica: Pharmaceutical Sales, 2000 - 2006
- Medley: International Agreements, 1992 - 2005
- Medley: Sales, 2006 - 2007
- Sopharma: Financial Data, 1999 - 2007 (Leva 000s)
- Labopharm: Financial Results, 2004 - 2008 (C$000s)
- Orbus Pharma: Rx Development Complete
- Orbus Pharma: Rx Under Development
- Orbus Pharma: Financial Results, 2003 - 2008 (C$000s)
- Orbus Pharma: Financial Results by Geography, 2007 - 2008 (C$000s)
- Andromaco: Financial Results, 2000 - 2007
- Biosano: Product Portfolio, 2008
- Simcere Pharmaceutical Group: Financial Results, 2004 - 2008 (RMB000s)
- Alembic: Financial Results, 2003 - 2009 (Rs millions)
- Aurobindo Pharma ANDA Approvals, 2002-09
- Aurobindo Pharma: Financial Results, 2004 - 2008 (Rs millions)
- Biocon: Financial Results, 2004 - 2009 (Rs millions)
- Gland Pharma ANDA Approvals, 2002-09
- Glenmark Pharmaceuticals / Glenmark Generics ANDA Approvals, 2002-09
- Glenmark Pharmaceuticals: Consolidated Financial Results (Rs millions)
- Glenmark Pharmaceuticals: Consolidated Financial Results by Business (Rs millions)
- Hetero Drugs ANDA Approvals, 2002-09
- Indoco Remedies: Financial Results (Rs millions)
- Unique Pharmaceutical Laboratories ANDA Approvals, 2002-09
- JB Chemicals & Pharmaceuticals: Financial Results, FY2004-5 - FY2008-9 (Rs millions)143
- Trigen Laboratories / Cadista Pharmaceuticals / Jubilant Pharmaceuticals ANDA Approvals, 2002-09
- Jubilant Organosys: Standalone Financial Results, FY2008 - FY2009 (Rs millions)
- Lupin Laboratories ANDA Approvals, 2002-09
- Lupin Laboratories: Consolidated Financial Results, FY2004 - 2009 (Rs millions)
- Natco Pharma ANDA Approvals, 2002-09
- Natco Pharma: Standalone Financial Results, 2004 - 2008 (Rs millions)
- Orchid Healthcare ANDA Approvals, 2002-09
- Orchid Chemicals & Pharmaceuticals: FY2004-5 - FY2007-8 results (Rs millions)
- Akorn-Strides ANDA Approvals, 2002-09
- Strides Arcolab: Consolidated Financial Results, 2005 - 2008 (Rs millions)
- Sun Pharmaceutical Laboratories ANDA Approvals, 2002-09
- Sun Pharmaceutical Industries: Financial Results, 2005 - 2008 (Rs millions)
- Torrent Pharmaceuticals ANDA Approvals, 2002-09
- Torrent Pharmaceuticals: Financial Results, 2007 - 2008 (Rs millions)
- Reliance GeneMedix: Financial Results (000s)
- Dexcel ANDA Approvals, 2002-09
- Taro Pharmaceutical Industries ANDA Approvals, 2002-09
- Taro Pharmaceutical Industries: Financial Results, 2000 - 2005 (US$000s)
- Taro Pharmaceutical Industries: Sales by Location, 2002 - 2005 (US$000s)
- Taro Pharmaceutical Industries: Estimated Results for Year Ended 31st December 2008 (US$000s)
- Taro Pharmaceutical Industries: Restatements for 2004 and 2005 (US$000s)
- Eurand ANDA Approvals, 2002-09
- Nichi-Iko: Medium Term Business Plan Goals (¡Í millions)
- Towa Pharmaceutical: Financial Results, FY2004 - FY2008 (¡Í millions)
- Hikma: 2008 filings
- Hikma Pharmaceuticals ANDA Approvals, 2002-09
- West-Ward ANDA Approvals, 2002-09
- Hikma: Financial Results, 2006 - 2008 (US$000s)
- Partnering in the Global Generics Industry 2009: A guide to companies
- xxviii October 2009
- ¨Ï Espicom Business Intelligence
- Hikma: Financial Results by Region, 2006 - 2008 (US$000s)
- Grindeks Group: Financial Results, 2004 - 2008 (LVL000s)
- Grindeks Group: Sales by Location, 2004 - 2008 (LVL000s)
- Sanitas: Group Financial Results, 2002 - 2008 (LTL000s)
- Sanitas: Selected Financial Results by Region, 2004 - 2008 (LTL000s)
- Antibiotice: Financial Results, 2002 - 2007
- Pharmstandard: Production by Facility, 2007
- Pharmstandard: Financial Results, 2004 - 2008 (R millions)
- Pharmstandard: Pharmaceutical Sales, 2006 - 2008
- Cipla Medpro: Group Financial Results (R000s)
- EastPharma: Financial Results, 2006 and 2009 (US$000s)
- Goldshield: Financial Results, 2003 - 2009 (000s)
- Goldshield: Sales by Region, 2006 - 2009 (000s)
- Goldshield: Selected Sales by Segment, 2006 - 2009 (000s)
- ProStrakan: Financial Results, 2002 - 2008 ( millions)
- ProStrakan: Selected Financial Results by Destination, 2002 - 2008 ( millions)
- American Pharmaceutical Partners ANDA Approvals, 2002-06
- Abraxis ANDA Approvals, 2006-08
- APP Pharmaceuticals ANDA Approvals, 2008-2009
- Akorn ANDA Approvals, 2002-09
- Akorn-Strides ANDA Approvals, 2002-09
- Akorn: Financial Results, 2002 - 2008 (US$000s)
- Amneal Pharmaceuticals ANDA Approvals, 2006-09
- Akyma Pharmaceuticals ANDA Approvals, 2002-09
- Interpharm ANDA Approvals, 2002-09
- Amphastar Pharmaceuticals ANDA Approvals, 2002-09
- International Medication Systems ANDA Approvals, 2002-09
- Anchen Pharmaceuticals ANDA Approvals, 2002-09
- Banner Pharmacaps ANDA Approvals, 2002-09
- Bedford Laboratories ANDA Approvals, 2002-09
- Ben Venue Laboratories ANDA Approvals, 2002-09
- Bio-Nucleonics ANDA Approvals, 2002-09
- Boca Pharmacal ANDA Approvals, 2002-09
- Caraco Pharmaceutical Laboratories ANDA Approvals, 2002-09
- Caraco Pharmaceutical Laboratories: Financial Results, FY2005 - FY2009 (US$000s)
- Carolina Medical Products ANDA Approvals, 2002-09
- Cedar Pharmaceuticals ANDA Approvals, 2002-09
- Cephazone Pharma ANDA Approvals, 2002-09
- CorePharma ANDA Approvals, 2002-09
- Cypress Pharmaceutical ANDA Approvals, 2002-09
- Ferndale Laboratories ANDA Approvals, 2002-09
- Fleming & Company Pharmaceuticals ANDA Approvals, 2002-09
- Altana ANDA Approvals, 2002-09
- G&W Laboratories ANDA Approvals, 2002-09
- GeneraMedix ANDA Approvals, 2002-09
- Glades Pharmaceuticals ANDA Approvals, 2002-09
- GC Hanford Manufacturing ANDA Approvals, 2002-09
- Harmony Labs ANDA Approvals, 2002-09
- Hi-Tech Pharmacal ANDA Approvals, 2002-09
- Hi-Tech Pharmacal: FY2005 - FY2009 Results (US$ millions)
- Impax Laboratories ANDA Approvals, 2002-09
- Impax Laboratories: Financial Results, 2004 - 2008 (US$000s)
- Indicus Pharmaceuticals ANDA Approvals, 2002-09
- InvaGen Pharmaceuticals ANDA Approvals, 2002-09
- KUDCo ANDA Approvals, 2002-09
- KV Pharmaceuticals / Ethex ANDA Approvals, 2002-09
- KV Pharmaceutical: Financial Results, 2002 - 2008 (US$ millions)
- KVK-Tech ANDA Approvals, 2002-09
- Luitpold Pharmaceuticals ANDA Approvals, 2002-09
- Lyne Laboratories ANDA Approvals, 2002-09
- Mallinckrodt ANDA Approvals, 2002-09
- Mikart ANDA Approvals, 2002-09
- Neil Laboratories ANDA Approvals, 2002-09
- Nephron Pharmaceuticals ANDA Approvals, 2002-09
- Paddock Laboratories ANDA Approvals, 2002-09
- Parenta Pharmaceuticals ANDA Approvals, 2002-09
- Pharmaceutical Associates ANDA Approvals, 2002-09
- PharmaForce ANDA Approvals, 2002-09
- Prometheus Laboratories ANDA Approvals, 2002-09
- Roxane Laboratories ANDA Approvals, 2002-09
- RxElite ANDA Approvals, 2002-09
- Silarx Pharmaceuticals ANDA Approvals, 2002-09
- Spear Pharmaceuticals ANDA Approvals, 2002-09
- Stiefel ANDA Approvals, 2002-09
- SuperGen ANDA Approvals, 2002-09
- SuperGen: Financial Results, 2004 - 2008 (US$ millions)
- Three Rivers ANDA Approvals, 2002-09
- Mutual Pharmaceutical Company ANDA Approvals, 2002-09
- Upsher-Smith Laboratories ANDA Approvals, 2002-09
- Vista Pharmaceuticals ANDA Approvals, 2002-09
- VistaPharm ANDA Approvals, 2002-09
- X-GEN Pharmaceuticals ANDA Approvals, 2002-09